Market-View-Feature-Image

View on market: Stay Cautious, be with quality business:

Asian equities were volatile on Friday and US futures fell amid disappointment over technology earnings. An Asian share index edged up amid mixed performance in Japan, South Korea and Australia. S&P 500 and Nasdaq 100 futures retreated. At 6:45 am, the Singapore-traded SGX Nifty — an early barometer of India’s benchmark Nifty 50 — rose 0.14% to 16,642.50 points. The euro trimmed an advance sparked by the European Central Bank’s 50 basis-point interest-rate hike, the first increase in 11 years. Crude traded around $96 a barrel. Gold and Bitcoin were both little changed.

Economic Calendar:

  • USD : Services PMI (Jul) 22nd July, 2022
  • USD : Manufacturing PMI (Jul) 22nd July, 2022
  • INR : FX Reserves, USD 22nd July, 2022
  • INR : M3 Money Supply 27th July, 2022

Q1FY23 Result Today: Bandhan Bank, Coforge Ltd., Crompton Greaves Consumer Electricals Ltd, Finolex Industries, HDFCAMC, JSW Steel, Reliance Industries, Ultratech Cement

Q1FY23 Result:

ICICI Securities Q1 FY23 (Consolidated, YoY) recorded a 12% year-on-year decline in consolidated profit at Rs 273.6 crore for the quarter ended June 2022 and profit before tax was also lower by 12% at Rs 367 crore. Revenue grew by 6.5% YoY to Rs 793.55 crore supported by interest income and income from services, but impacted by lower brokerage income.

JSW Energy Q1 FY23 (Consolidated, YoYrecorded a 179% year-on-year increase in consolidated profit at Rs 560 crore for the quarter ended June 2022, backed by exceptional income and strong operating income as well as topline performance. Revenue grew by 67.5% YoY to Rs 3,115 crore and EBITDA increased by 34% to Rs 1,111 crore for the quarter.

SRF Q1 FY23 (Consolidated, YoY) recorded a 54% YoY increase in Profit After Tax(PAT) at Rs 608 crore in Q1FY23, backed by revenue and operating performance. Consolidated revenue grew by 44% YoY to Rs 3,895 crore in Q1FY23, and earnings before interest and tax (EBIT) increased 58% YoY to Rs 938 crore during the quarter.

Brokerage Radar:

MS ON SRF: OW, TP Rs 2757

Core PAT of Rs6.4bn (+62% YoY, +6% QoQ) came in 10% ahead of street est led by fluorochemicals; Co’s outlook on chemicals remains upbeat; Despite strong packaging EBIT growth, Co saw signs of demand weakness, which expect to intensify

JPM ON RBL BANK: Neutral, TP Rs 105

Bank highlights no AQ strain post CEO change; ROEs will take time to reflate on opex strain; Core PPOP declined 26% y/y driven by elevated opex., Loan book was flat q/q with decline in retail book offset by wholesale growth

MS ON CYIENT: UW, TP Rs 680

In-line revenue, but miss on margins; Rising macro uncertainties, lack of broad-based growth, & higher attrition pose risk to execution of guidance; EBIT margin at 11.5% (-298bps qoq/-164bps yoy) was weak vs. 11.9% est

International Markets:

U.S & Europe:

Particulars      21st July Chg. Chg.(%)
Nasdaq 12,059.61 161.96 1.36
Dow 32,036.90 162.06 0.51
FTSE 7,270.51 6.2 0.09
CAC 6,201.11 16.45 0.27
DAX 13,246.64 -35.34 -0.27
Dow Fut.* 31,979.50 -57.4 -0.18

Asian markets:

Particulars      22nd July Chg. Chg.(%)
SGX Nifty 16,635.00 17.5 0.11
Nikkei 27,870.33 67.33 0.24
Straits Times 3,175.67 23.37 0.74
Hang Seng 20,702.94 128.31 0.62
Shanghai 3,288.67 16.67 0.51

ADR Watch:

Particulars       21st July Chg. Chg.(%)
Dr. Reddy 55.84 0.57 1.03
HDFC Bank 58.27 0.67 1.16
ICICI Bank 19.81 0.25 1.28
Infosys 19.21 0.49 2.62
Tata Motor 28.72 0.53 1.88
Wipro 16.50 0.00 0.00

Commodities & Currency:

Particulars Current Price Chg.(%)
USD/INR 79.95 -0.06
Brent 105.23  1.32
Gold 1713.45 0.00
Silver 18.705 -0.07

FIIs & DII:

Particulars 21st July 20th July
FIIs 1799.32 1780.94
DIIs -312.29 -230.22

News Update:

Welspun Corp: The company announced the commissioning of its blast furnace and sinter plant, and TMT bars manufacturing facility at Anjar, Gujarat through its wholly owned subsidiaries. The blast furnace can produce approximately 5 lakh MT of hot metal per annum and TMT bar facility has a capacity of 3.5 lakh MT per annum.

Emami: The company acquired 30 percent stake in a pet-care start-up Cannis Lupus Services India. Cannis Lupus under the brand ‘FurBallStory’ would thus be focusing on the fast-growing pet care segment with its ayurvedic range of solutions for common and recurrent ailments in pets, especially dogs.

Biocon: The US Food and Drug Administration has concluded a pre-approval inspection for Site 3 of Biocon at Hyderabad in Telangana on July 20, with three observations. The company will be addressing within the stipulated time and stands committed to the quality, safety and efficacy of its products.

Source: Moneyontrol, Livemint,, Bloomberg, Investing

Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014

Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.
For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)
Disclosure Appendix
Analyst Certification (For Reports)
Israil Khan, Elite Wealth Limited, suhail@elitewealth.in
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.
For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
Research Excerpts
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.
Company-Specific Disclosures
Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in, or emailing research@elitestock.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.
Options related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in
Other Disclosures
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.
Ownership and material conflicts of interest Disclosure
Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.
Country Specific Disclosures
India – For private circulation only, not for sale.
Legal Entities Disclosures
Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone:011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in
EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
1. Reports
a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
(b) EWL or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
(c) EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
2. Compensation
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
(c) EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(d) EWL or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(e) EWL or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research report.
3 In respect of Public Appearances
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL